Sudeep Pharma Board Meeting on Oct 28 to Approve Financial Results

Sudeep Pharma Ltd has announced that its Board of Directors will convene on October 28, 2026. The primary agenda item is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. Concurrently, the company has informed about the closure of its trading window from October 1, 2026, until 48 hours after the declaration of these financial results, with the window reopening on October 31, 2026.